A clinical roadmap for base and prime editing
- 1 September 2025
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Bioengineering
- Vol. 3 (11) , 914-916
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic DiseaseNew England Journal of Medicine, 2025
- High-dimensional temporal mapping of CAR T cells reveals phenotypic and functional remodeling during manufacturingMolecular Therapy, 2025
- CRISPR-Based Therapy for Hereditary AngioedemaNew England Journal of Medicine, 2025
- Enhancing pediatric access to cell and gene therapiesNature Medicine, 2024
- The Fate(s) of CAR T-Cell Therapy: Navigating the Risks of CAR+ T-Cell MalignancyBlood Cancer Discovery, 2024
- Gene Editing for CEP290 -Associated Retinal DegenerationNew England Journal of Medicine, 2024
- Exagamglogene Autotemcel for Severe Sickle Cell DiseaseNew England Journal of Medicine, 2024
- Exagamglogene Autotemcel for Transfusion-Dependent β-ThalassemiaNew England Journal of Medicine, 2024
- Past, present, and future of CRISPR genome editing technologiesCell, 2024
- CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-ThalassemiaNew England Journal of Medicine, 2021